Results

Total Results: 4,884 records

Showing results for "end stage renal".

4861. App-D-Surv-Report-3-Noninvasive-Nonpharma 0 (xls file)
      effectivehealthcare.ahrq.gov/sites/default/files/related_files/app-d-surv-report-3-noninvasive-nonpharma_0.xlsx
      January 01, 2022 - all six treatment sessions and to attend follow-up visits for at least 12 months (52 weeks) after the end … 11.69), p=NR TSK: 23.02 (6.26) vs. 25.13 (6.85), p=NR NR NR One serious adverse event occurred at the end … within each treatment arm (yoga=A1 and A2, PT=B1 and B2) did not differ in primary outcomes at the end … Recieved 12 weekly sessions of RFCBT at the end of the study. A vs. … sciatica; ongoing pregnancy; hypertension, cardiovascular disease, diabetes mellitus, liver disease, renal

4862. App-D-Surv-Report-3-Noninvasive-Nonpharma 0 (xls file)
      effectivehealthcare-admin.ahrq.gov/sites/default/files/related_files/app-d-surv-report-3-noninvasive-nonpharma_0.xlsx
      January 01, 2022 - all six treatment sessions and to attend follow-up visits for at least 12 months (52 weeks) after the end … 11.69), p=NR TSK: 23.02 (6.26) vs. 25.13 (6.85), p=NR NR NR One serious adverse event occurred at the end … within each treatment arm (yoga=A1 and A2, PT=B1 and B2) did not differ in primary outcomes at the end … Recieved 12 weekly sessions of RFCBT at the end of the study. A vs. … sciatica; ongoing pregnancy; hypertension, cardiovascular disease, diabetes mellitus, liver disease, renal

4863. Infectious Disease Including HIV/AIDS #09 (pdf file)
      effectivehealthcare.ahrq.gov/sites/default/files/09_infectiousdisease_potential_high_impact_june_2012.pdf
      January 01, 2012 - Based on this input, our overall assessment is that this intervention is in the higher end of the high-potential-impact … Based on this input, our overall assessment is that this intervention is in the lower end of the high-potential … Decline in renal function and proteinuria may be related to long-term use of emtricitabine/tenofovir … Based on this input, our overall assessment is that this intervention is in the higher end of the high-potential … Based on this input, our overall assessment is that this intervention is in the higher end of the high

4864. Infectious Disease Including HIV/AIDS #09 (pdf file)
      effectivehealthcare-admin.ahrq.gov/sites/default/files/09_infectiousdisease_potential_high_impact_june_2012.pdf
      January 01, 2012 - Based on this input, our overall assessment is that this intervention is in the higher end of the high-potential-impact … Based on this input, our overall assessment is that this intervention is in the lower end of the high-potential … Decline in renal function and proteinuria may be related to long-term use of emtricitabine/tenofovir … Based on this input, our overall assessment is that this intervention is in the higher end of the high-potential … Based on this input, our overall assessment is that this intervention is in the higher end of the high

4865. HEALTHCARE COST AND UTILIZATION PROJECT — HCUP (pdf file)
      hcup-us.ahrq.gov/db/nation/nis/NISIntroduction2013.pdf
      November 01, 2015 - Standard formulas for a stratified, single-stage cluster sample without replacement should still be … software packages that perform calculations for numerous statistics arising from the stratified, single-stage … (0) Comorbidity is not present, (1) Comorbidity is present CM_RENLFAIL AHRQ comorbidity measure: Renal …  More than 50 percent of AHA respondents report statistics for fiscal years, which often end in

4866. Research Findings #25: Trends in the Pharmaceutical Treatment of Hypertension, 1997 to 2003
      meps.ahrq.gov/data_files/publications/rf25/rf25.shtml
      January 01, 2006 - In 1997, JNC VI advised that in the absence of data documenting equal long-term cardiac and renal protection

4867. Research Findings #25: Trends in the Pharmaceutical Treatment of Hypertension, 1997 to 2003 (pdf file)
      meps.ahrq.gov/data_files/publications/rf25/rf25.pdf
      July 01, 2006 - In 1997, JNC VI advised that in the absence of data documenting equal long-term cardiac and renal protection

4868. Research Findings #12: Health Care Expenses in the United States, 1996
      meps.ahrq.gov/data_files/publications/rf12/rf12.shtml
      December 01, 2000 - elderly, persons receiving Social Security disability payments, and most persons with end-stage … renal disease.

4869. Treatment Strategies for Patients with Lower Extremity Chronic Venous Disease (LECVD): Disposition of Comments (pdf file)
      www.ahrq.gov/sites/default/files/wysiwyg/research/findings/ta/comments/lecvd-comments.pdf
      April 01, 2017 - remind (or emphasize to) the reader that effectiveness and the like may not be the most important end … studies by Kirsner and Marston were both considered during the review but excluded at the abstract stage … Reviewer #6 from the Society for Vascular Surgery and American Venous Forum Introduction Page 1, end … about the potential role of end-points that are not emphasized here (like cost-effectiveness), but … patients, requires exposure to iodinated contrast (with all known risks, including allergy/anaphylaxis, renal

4870. Screening for and Treatment of Suicide Risk Relevant to Primary Care: A Systematic Review for the USPSTF (pdf file)
      www.uspreventiveservicestaskforce.org/home/getfilebytoken/vxPM4Bo9RXZGUDH6MWnDht
      May 01, 2013 - Ann Intern Med. 2013;158:741-754. www.annals.org For author affiliations, see end of text. … 11 of these 49 trials; almost all of the new trials were published in 2003 or later, well after the end … A decision analysis of long-term lithium treatment and the risk of renal failure. … 264) Citations screened after duplicates removed (n = 3925)* Citations excluded at title/abstract stage

4871. PULMONARY with "Discussions" in Exec Summary (pdf file)
      effectivehealthcare.ahrq.gov/sites/default/files/pulmonary-horizon-scan-high-impact-1506.pdf
      October 01, 2015 - Based on this input, our overall assessment is that this intervention is in the high end of the high-impact-potential … rejection, arrhythmias, BOS, narrowing of air passages, primary graft dysfunction or lung not responding, renal

4872. PULMONARY with "Discussions" in Exec Summary (pdf file)
      effectivehealthcare-admin.ahrq.gov/sites/default/files/pulmonary-horizon-scan-high-impact-1506.pdf
      October 01, 2015 - Based on this input, our overall assessment is that this intervention is in the high end of the high-impact-potential … rejection, arrhythmias, BOS, narrowing of air passages, primary graft dysfunction or lung not responding, renal

4873. Evidence Summary: Colorectal Cancer: Screening | United States Preventive Services Taskforce
      www.uspreventiveservicestaskforce.org/uspstf/document/evidence-summary/colorectal-cancer-screening
      June 15, 2016 - primary studies informing the key questions (eMethods in the Supplement) that were published from the end … Association between early stage colon neoplasms and false-negative results from the fecal immunochemical … Incidental finding of renal masses at unenhanced CT: prevalence and analysis of features for guiding

4874. Screening for Thyroid Disease: Systematic Evidence Review (pdf file)
      www.ahrq.gov/downloads/pub/prevent/pdfser/thyrser.pdf
      January 01, 2004 - Characteristics Known history of thyroid disease Cooper et al, 1984(75) Previously treated Graves' disease, stage … Placebo 11 (mean) 3.6-55.3 (range) mean TSH in control group increased to ~15 by the end … Placebo 12.8 (mean) 5-50 (range) NR/NR/66 3/63 Caraccio et al, 2002(102) Diabetes, renal

4875. Archived: Evidence Summary: Colorectal Cancer: Screening | United States Preventive Services Taskforce
      www.uspreventiveservicestaskforce.org/uspstf/document/evidence-summary/colorectal-cancer-screening-june-2016
      June 15, 2016 - primary studies informing the key questions (eMethods in the Supplement) that were published from the end … Association between early stage colon neoplasms and false-negative results from the fecal immunochemical … Incidental finding of renal masses at unenhanced CT: prevalence and analysis of features for guiding

4876. Archived: Evidence Summary: Suicide Risk in Adolescents, Adults and Older Adults: Screening | United States Preventive Services Taskforce
      www.uspreventiveservicestaskforce.org/uspstf/document/evidence-summary20/suicide-risk-in-adolescents-adults-and-older-adults-screening
      April 15, 2013 - 11 of these 49 trials; almost all of the new trials were published in 2003 or later, well after the end … A decision analysis of long-term lithium treatment and the risk of renal failure. … After duplicates were removed, 3,925 unique citations were screened at the title/abstract stage.

4877. Untitled Document
      meps.ahrq.gov/data_files/publications/rf21/rf21v3.html
      April 01, 2004 - for the elderly, persons receiving Social Security disability payments, and most persons with end-stage … renal disease. … If data were not collected at the end of the year because the sample person was out of scope (e.g. … MSA data are based on MSA status as of the end of the reference year.

4878. AHRQ Multiple Chronic Conditions Research Summit: Speaker Biosketches | Agency for Healthcare Research and Quality
      www.ahrq.gov/patient-safety/settings/long-term-care/resource/multichronic/summit-bios.html
      November 01, 2021 - Services, a health services researcher in the Knowledge and Evaluation Research (KER) Unit and the Late Stage … physician and Director of Research for the Pediatric Advance Care Team (which provides palliative, end-of-life … former Chair of the Public Policy Committee and a member of the Board of Directors of the Mid-Atlantic Renal … Medicaid Services Evidence Advisory Committee, was appointed to the Michigan Governor’s Commission on End

4879. Disposition of Comments Report for Testing of CYP2C19 Variants and Platelet Reactivity for Guiding Antiplatelet Treatment (pdf file)
      effectivehealthcare.ahrq.gov/sites/default/files/related_files/antiplatelet-treatment_disposition-comments.pdf
      September 25, 2013 - (e.g., patients with heart failure, obesity, diabetes, acute coronary syndrome presentation, and renal … aggregation (FPA), which is related to light transmission measured at a specific time point near the end

4880. Disposition of Comments Report for Testing of CYP2C19 Variants and Platelet Reactivity for Guiding Antiplatelet Treatment (pdf file)
      effectivehealthcare-admin.ahrq.gov/sites/default/files/related_files/antiplatelet-treatment_disposition-comments.pdf
      September 25, 2013 - (e.g., patients with heart failure, obesity, diabetes, acute coronary syndrome presentation, and renal … aggregation (FPA), which is related to light transmission measured at a specific time point near the end